Related Experiment Video

Updated: Sep 29, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

[Guillain-Barré syndrome in childhood. Characteristic course and therapeutic possibilities]

R Korinthenberg1, M Sauer

  • 1Abteilung Neuropädiatrie und Muskelerkrankungen, Albert-Ludwigs-Universität, Freiburg.

Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde
|November 1, 1992
PubMed

Insights

Childhood Guillain-Barré syndrome (GBS) is rare but can be severe, often requiring ventilation. Treatments like plasmapheresis and immunoglobulins show promise, though adult study results require cautious application in pediatric GBS.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Immunology

Context:

  • Guillain-Barré syndrome (GBS) in children presents unique challenges compared to adults.
  • Pediatric GBS incidence is lower, but clinical severity, including respiratory insufficiency and cardiac arrhythmias, can be substantial.
  • While most children recover fully, treatment efficacy data primarily comes from adult studies, necessitating cautious extrapolation.

Purpose:

  • To review the current understanding of pediatric Guillain-Barré syndrome (GBS).
  • To evaluate the efficacy and applicability of various therapeutic interventions in children with GBS.
  • To highlight the differences in treatment approaches between pediatric and adult GBS cases.

Summary:

  • Childhood GBS is less common than adult GBS but can lead to severe outcomes, with 10-25% needing mechanical ventilation.
  • Cardial arrhythmias pose a significant threat, although over 90% of affected children achieve complete recovery.
  • Steroids are ineffective in acute GBS but may benefit chronic inflammatory demyelinating polyneuropathy (CIDP).
  • Plasmapheresis and intravenous immunoglobulins (IVIg) demonstrate efficacy in severe GBS and CIDP, reducing recovery times.
  • Caution is advised when applying adult treatment guidelines to children, especially for IVIg in less severe pediatric cases.

Impact:

  • Provides critical insights into the management of pediatric Guillain-Barré syndrome.
  • Informs clinical decision-making regarding the use of plasmapheresis and immunoglobulins in children.
  • Emphasizes the need for cautious interpretation of adult treatment trial data for pediatric populations.
  • Highlights the potential benefits of immunoglobulins and plasmapheresis in improving outcomes for severe pediatric GBS.
  • Suggests reserving IVIg for controlled studies in less severe pediatric GBS cases pending further evidence.

More Related Videos

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...